Consonance Capital - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2005
Consonance Capital is a US-based investment firm specializing in the healthcare sector. The firm focuses on private equity investments, including growth equity, leveraged buyouts, and recapitalizations. Consonance Capital typically engages in various investment stages, from pre-seed to post-IPO equity rounds. Their investment strategy is designed to support companies at multiple growth phases within the healthcare industry.
Notable portfolio companies include Civic Eagle, Mersana Therapeutics, Payhippo, Silence Therapeutics, and Surrozen. The firm is co-led by key partners Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. Consonance Capital distinguishes itself through its deep expertise in healthcare and offers unique value-add services such as strategic advisory and management support to its portfolio companies.
Consonance Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count5
Total Portfolio Exits1
Top Investment Stages
Pre-Seed1 (50.0%)
Series A1 (50.0%)
Stage Mix
Pre-Seed 50%Series A 50%
Concentration shown as share of disclosed investments by stage.